Výsledky vyhledávání - Shawn D. Spencer
- Zobrazuji výsledky 1 - 9 z 9
-
1
A sensitive and rapid ultra HPLC–MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma Autor Cody J. Peer, Shawn D. Spencer, Dustin A.H. VanDenBerg, Michael Pacanowski, Richard B. Horenstein, William D. Figg
Vydáno 2011Artigo -
2
Biphasic burst and sustained transdermal delivery in vivo using an AI-optimized 3D-printed MN patch Autor Arvind Bagde, Satyanarayan Dev, Lalitha Madhavi Konila Sriram, Shawn D. Spencer, Anilkumar Kalvala, Aakash Nathani, Oluwaseyi Salau, Keb Mosley-Kellum, Harshil Dalvaigari, Swaminathan Rajaraman, Avra Kundu, Mandip Singh
Vydáno 2023Artigo -
3
A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors Autor Arun Rajan, Corey A. Carter, Ronan J. Kelly, Martin Gutierrez, Shivaani Kummar, Éva Szabó, Mary Ann Yancey, Jiuping Ji, Baskar Mannargudi, Sukyung Woo, Shawn D. Spencer, William D. Figg, Giuseppe Giaccone
Vydáno 2012Artigo -
4
The CYP2C19*17 variant is not independently associated with clopidogrel response Autor Joshua P. Lewis, Sarah H. Stephens, R B Horenstein, Jeffery R. O’Connell, Kathleen A. Ryan, Cody J. Peer, William D. Figg, Shawn D. Spencer, Michael Pacanowski, Braxton D. Mitchell, Alan R. Shuldiner
Vydáno 2013Artigo -
5
A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer Autor Lee S. Rosen, Herbert I. Hurwitz, Michael K. Wong, Jonathan W. Goldman, David S. Mendelson, William D. Figg, Shawn D. Spencer, Bonne J. Adams, Delia Alvarez, Ben K. Seon, Charles P. Theuer, Bryan R. Leigh, Michael S. Gordon
Vydáno 2012Artigo -
6
Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors Autor Shivaani Kummar, Mark Raffeld, Lamin Juwara, Yvonne Horneffer, Agnes Strassberger, Deborah Allen, Seth M. Steinberg, Annamaria Rapisarda, Shawn D. Spencer, William D. Figg, Xiaohong Chen, Barış Türkbey, Peter L. Choyke, Anthony J. Murgo, James H. Doroshow, Giovanni Melillo
Vydáno 2011Artigo -
7
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer Autor Ronan J. Kelly, Anish Thomas, Arun Rajan, Guinevere Chun, Ariel López-Chávez, Éva Szabó, Shawn D. Spencer, C.A. Carter, Udayan Guha, Sean Khozin, Srinivasu Poondru, C. Van Sant, Anne Keating, Seth M. Steinberg, William D. Figg, Giuseppe Giaccone
Vydáno 2013Artigo -
8
Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia Autor Thomas A. Waldmann, Kevin C. Conlon, Donn M. Stewart, TatYana A. Worthy, John E. Janik, Thomas A. Fleisher, Paul S. Albert, William D. Figg, Shawn D. Spencer, Mark Raffeld, Jean Decker, Carolyn K. Goldman, Bonita R. Bryant, Michael Petrus, Stephen P. Creekmore, John C. Morris
Vydáno 2012Artigo -
9
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response Autor Joshua P. Lewis, Richard B. Horenstein, Kathleen A. Ryan, Jeffrey R. O’Connell, Quince Gibson, Braxton D. Mitchell, Keith Tanner, Sumbul Chai, Kevin P. Bliden, Udaya S. Tantry, Cody J. Peer, William D. Figg, Shawn D. Spencer, Michael Pacanowski, Paul A. Gurbel, Alan R. Shuldiner
Vydáno 2012Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Pharmacology
Chemistry
Chemotherapy
Pharmacokinetics
Aspirin
Biochemistry
Biology
Cancer
Clopidogrel
Gastroenterology
Oncology
Active metabolite
Adverse effect
Antibody
Chromatography
Cisplatin
Immunology
Metabolite
Organic chemistry
Phases of clinical research
Aldesleukin
Analyte
Anemia
Angiogenesis
Biomedical engineering
Biotechnology
CD34
CYP2C19